GlaxoSmithKline plc ('GSK')
Directorate Change
Further to the announcement made on 3 October 2014, regarding the appointment of Mr Urs Rohner as a Non-Executive Director and member of GSK's Remuneration Committee, with effect from 1 January 2015, GSK confirms that there are no further disclosures to be made in accordance with Listing Rule 9.6.13R.
V A Whyte
Company Secretary
10 October 2014
